184 related articles for article (PubMed ID: 6472528)
21. Gel-filtration on psoriasic and uremic serum and dialysis fluid.
Lamperi S; Buoncristiani U; Carozzi S; Cozzari M; Icardi A; Trasforini D
Artif Organs; 1981; 4 Suppl():156-9. PubMed ID: 7295083
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of platelet function by uremic middle molecules.
Bazilinski N; Shaykh M; Dunea G; Mamdani B; Patel A; Czapek E; Ahmed S
Nephron; 1985; 40(4):423-8. PubMed ID: 4022211
[TBL] [Abstract][Full Text] [Related]
23. Preparative isolation of middle molecular weight fractions from the hemofiltrate of patients with chronic uremia.
Brunner H; Mann H; Essers U; Schultheis R; Byrne T; Heintz R
Artif Organs; 1978 Nov; 2(4):375-7. PubMed ID: 743009
[TBL] [Abstract][Full Text] [Related]
24. [Hydrophobic uremic middle molecules in hemofiltrate of a dialysis patient].
Konobu K; Matsumoto T; Sawanishi K
Nihon Jinzo Gakkai Shi; 1988 Feb; 30(2):151-60. PubMed ID: 3386019
[No Abstract] [Full Text] [Related]
25. [Biochemical definition of uremia].
Ringoir S
Verh K Acad Geneeskd Belg; 1981; 43(2):105-19. PubMed ID: 7314875
[No Abstract] [Full Text] [Related]
26. Investigations on clinico-chemical correlations in uraemic polyneuritis.
Man NK; Cueuille G; Zingraff J; Drueke T; Jungers P; Sausse A; Billon JP; Funck-Brentano JL
Proc Eur Dial Transplant Assoc; 1975; 11():214-21. PubMed ID: 1197256
[No Abstract] [Full Text] [Related]
27. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
Ringoir SM; van Landschoot N; de Smet R
Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
[TBL] [Abstract][Full Text] [Related]
28. A defense of the middle molecule hypothesis.
Funck-Brentano JL; Cueille GF; Man NK
Kidney Int Suppl; 1978 Jun; (8):S31-5. PubMed ID: 278894
[No Abstract] [Full Text] [Related]
29. The effect of hemodialysis on endogenous middle molecules in uremic patients.
Asaba H; Fürst P; Oulés R; Yahiel V; Zimmerman L; Bergström J
Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
[TBL] [Abstract][Full Text] [Related]
30. Search for peptidic "middle molecules" in uremic sera: isolation and chemical identification of fibrinogen fragments.
Kaplan B; Cojocaru M; Unsworth E; Knecht A; Martin BM
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):141-53. PubMed ID: 14552825
[TBL] [Abstract][Full Text] [Related]
31. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
Popławski A; Myśliwiec M
Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
[No Abstract] [Full Text] [Related]
32. Removal of high-molecular-weight toxins.
Hörl WH
Contrib Nephrol; 1992; 96():138-44. PubMed ID: 1740048
[No Abstract] [Full Text] [Related]
33. [Uremic toxin and dialysis].
Nakagawa S
Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):430-2. PubMed ID: 988349
[No Abstract] [Full Text] [Related]
34. Hippuric acid as a marker.
Vanholder R; Schoots A; Cramers C; De Smet R; Van Landschoot N; Wizemann V; Botella J; Ringoir S
Adv Exp Med Biol; 1987; 223():59-67. PubMed ID: 3447451
[No Abstract] [Full Text] [Related]
35. Characterization of a 1100-1300 MW uremic neurotoxin.
Funck-Brentano JL; Man NK; Sausse A; Zingraff J; Boudet J; Becker A; Cueille GF
Trans Am Soc Artif Intern Organs; 1976; 22():163-7. PubMed ID: 951836
[No Abstract] [Full Text] [Related]
36. [Studies on the significance of middle molecular retention products as uremia toxins].
Goubeaud G; Leber HW; Schott HH
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1244-6. PubMed ID: 611827
[No Abstract] [Full Text] [Related]
37. Influence of dialysis membranes on the convective transport of middle molecules.
De Francisco AL; Gordillo J; Cotorruelo JG; Ruiz L; Gonzalez M; Morales P; Arias M
Int J Artif Organs; 1986 Nov; 9(6):421-6. PubMed ID: 3818117
[TBL] [Abstract][Full Text] [Related]
38. Methodology for identification of serum middle molecules.
Buzio C; Montagna G; Calderini C; Manari A; Migone L
Artif Organs; 1981; 4 Suppl():22-7. PubMed ID: 7295090
[TBL] [Abstract][Full Text] [Related]
39. Isolation and identification of canine plasma components suspected as uremic toxins.
Kawamura M; Ohashi F; Nagata Y; Takai N; Motoie H; Nishimura R; Sasaki N; Takeuchi A
J Vet Med Sci; 1993 Apr; 55(2):265-70. PubMed ID: 8513007
[TBL] [Abstract][Full Text] [Related]
40. [Uremic toxin and dialysis].
Kobayashi K; Maeda K; Kawaguchi S
Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):412-4. PubMed ID: 988343
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
